Protein-protein interaction inhibitors: advances in anticancer drug design (2016)
Source: Expert Opinion on Drug Discovery. Unidade: IFSC
Subjects: PROTEÍNAS, CRISTALOGRAFIA DE RAIOS X, NEOPLASIAS
ABNT
FERREIRA, Leonardo Luiz Gomes e OLIVA, Glaucius e ANDRICOPULO, Adriano Defini. Protein-protein interaction inhibitors: advances in anticancer drug design. Expert Opinion on Drug Discovery, v. 11, n. 10, p. 957-968, 2016Tradução . . Disponível em: https://doi.org/10.1080/17460441.2016.1223038. Acesso em: 17 out. 2024.APA
Ferreira, L. L. G., Oliva, G., & Andricopulo, A. D. (2016). Protein-protein interaction inhibitors: advances in anticancer drug design. Expert Opinion on Drug Discovery, 11( 10), 957-968. doi:10.1080/17460441.2016.1223038NLM
Ferreira LLG, Oliva G, Andricopulo AD. Protein-protein interaction inhibitors: advances in anticancer drug design [Internet]. Expert Opinion on Drug Discovery. 2016 ; 11( 10): 957-968.[citado 2024 out. 17 ] Available from: https://doi.org/10.1080/17460441.2016.1223038Vancouver
Ferreira LLG, Oliva G, Andricopulo AD. Protein-protein interaction inhibitors: advances in anticancer drug design [Internet]. Expert Opinion on Drug Discovery. 2016 ; 11( 10): 957-968.[citado 2024 out. 17 ] Available from: https://doi.org/10.1080/17460441.2016.1223038